Abstract
Background: Pelvic congestion syndrome (PCS) is a poorly understood condition that can be associated with chronic pelvic pain and could impact quality of life. The diagnosis is often made by exclusion of other causes of pelvic pain. Objective: The purpose of our review was to provide an update on the etiology, anatomy, physiology, identification, and the therapeutic management of PCS. Method: We conducted a literature review involving publications from 2003 to 2024 in PubMed, Elsevier, MEDLINE, as well as manual searches of primary and review articles using keywords such as “pelvic veins”, “embolization”, “venography”, “pelvic congestion syndrome”, and “chronic pelvic pain”. Conclusion: PCS remains poorly understood. Symptoms can be non-specific and difficult to distinguish from other diseases; yet it is an important cause of chronic pelvic pain in women. To date, there have been only a small number of randomized trials and high-level evidence is still lacking. Outlook: We call for an increased awareness of PCS and additional clinical studies in a large number of patients.
References
1.
O’Brien
MT
, Gillespie
DL
. Diagnosis and treatment of the pelvic congestion syndrome
. J Vasc Surg Venous Lymphat Disord
. 2015
;3
(1
):96
–106
. 2.
Knuttinen
MG
, Xie
K
, Jani
A
, Palumbo
A
, Carrillo
T
, Mar
W
. Pelvic venous insufficiency: imaging diagnosis, treatment approaches, and therapeutic issues
. AJR Am J Roentgenol
. 2015
;204
(2
):448
–58
. 3.
Kaufman
C
, Little
NA
. Pelvic congestion syndrome: a missed opportunity
. Indian J Radiol Imaging
. 2021
;31
(3
):539
–44
. 4.
Babunashvili
EL
, Son
DY
, Buyanova
SN
, Schukina
NA
, Popov
AA
, Chechneva
MA
, et al. Outcomes of laparotomic myomectomy during pregnancy for symptomatic uterine fibroids: a prospective cohort study
. J Clin Med
. 2023
;12
(19
):6406
. 5.
Favilli
A
, Mazzon
I
, Etrusco
A
, Dellino
M
, Laganà
AS
, Tinelli
A
, et al. The challenge of FIGO type 3 leiomyomas and infertility: exploring therapeutic alternatives amidst limited scientific certainties
. Int J Gynaecol Obstet
. 2024
;165
:975
–87
. 6.
Etrusco
A
, Laganà
AS
, Chiantera
V
, Vitagliano
A
, Cicinelli
E
, Mikuš
M
, et al. Feasibility and surgical outcomes of hysteroscopic myomectomy of FIGO type 3 myoma: a systematic review
. J Clin Med
. 2023
;12
(15
):4953
. 7.
Feghali
E
, Etrusco
A
, Haydamous
J
, Ayed
A
, Laganà
AS
, Chiantera
V
, et al. Concurrent diagnosis of adenomyosis and congenital uterine anomalies: a review
. J Pers Med
. 2023
;13
(5
):716
. 8.
Etrusco
A
, Laganà
AS
, Chiantera
V
, Mikuš
M
, Arsalan
HM
, d’Amati
A
, et al. Reproductive and oncologic outcomes in young women with stage IA and grade 2 endometrial carcinoma undergoing fertility-sparing treatment: a systematic review
. Biomolecules
. 2024
;14
(3
):306
. 9.
Bendek
B
, Afuape
N
, Banks
E
, Desai
NA
. Comprehensive review of pelvic congestion syndrome: causes, symptoms, treatment options
. Curr Opin Obstet Gynecol
. 2020
;32
(4
):237
–42
. 10.
Robertson
M
, McCuaig
R
. Pelvic congestion syndrome
. Australas J Ultrasound Med
. 2013
;16
(1
):26
–9
. 11.
Osman
AM
, Mordi
A
, Khattab
R
. Female pelvic congestion syndrome: how can CT and MRI help in the management decision
. Br J Radiol
. 2021
;94
(1118
):20200881
. 12.
Senechal
Q
, Echegut
P
, Bravetti
M
, Florin
M
, Jarboui
L
, Bouaboua
M
, et al. Endovascular treatment of pelvic congestion syndrome: visual analog scale follow-up
. Front Cardiovasc Med
. 2021
;8
:751178
. 13.
Nanavati
R
, Jasinski
P
, Adrahtas
D
, Gasparis
A
, Labropoulos
N
. Correlation between pelvic congestion syndrome and body mass index
. J Vasc Surg
. 2018
;67
(2
):536
–41
. 14.
Borghi
C
, Dell’Atti
L
. Pelvic congestion syndrome: the current state of the literature
. Arch Gynecol Obstet
. 2016
;293
(2
):291
–301
. 15.
Alsannan
B
, Laganà
AS
, Alhermi
J
, Almansoor
S
, Ayed
A
, Venezia
R
, et al. Prevalence of overactive bladder among overweight and obese women: a prospective cross-sectional cohort study
. Eur J Obstet Gynecol Reprod Biol
. 2024
;295
:59
–64
. 16.
Etrusco
A
, Mikuš
M
, D’Amato
A
, Barra
F
, Planinić
P
, Goluža
T
, et al. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity and treatment with metformin and GLP-1s
. Biomedicines
. 2024
;12
(3
):653
. 17.
Alsannan
B
, Alharmi
J
, Alrahal
F
, Al Mansoor
S
, Tulandi
T
. Prevalence and quality of life among overweight and obese women with different severity and types of urinary incontinence
. Med Princ Pract
. 2024
;33
(1
):47
–55
. 18.
Asciutto
G
, Asciutto
KC
, Mumme
A
, Geier
B
. Pelvic venous incompetence: reflux patterns and treatment results
. Eur J Vasc Endovasc Surg
. 2009
;38
(3
):381
–6
. 19.
Akhmetzianov
RV
, Bredikhin
RA
. Clinical efficacy of conservative treatment with micronized purified flavonoid fraction in female patients with pelvic congestion syndrome
. Pain Ther
. 2021
;10
(2
):1567
–78
. 20.
Favilli
A
, Etrusco
A
, Chiantera
V
, Laganà
AS
, Cicinelli
E
, Gerli
S
, et al. Impact of FIGO type 3 uterine fibroids on in vitro fertilization outcomes: a systematic review and meta-analysis
. Int J Gynaecol Obstet
. 2023
;163
(2
):528
–39
. 21.
Etrusco
A
, Barra
F
, Chiantera
V
, Ferrero
S
, Bogliolo
S
, Evangelisti
G
, et al. Current medical therapy for adenomyosis: from bench to bedside
. Drugs
. 2023
;83
(17
):1595
–611
. 22.
Zheng
W
, Sun
C
, Yang
J
, Wu
Y
. Unique case of pelvic congestion syndrome caused by a new communication branch of the portal-vena cava system
. J Cardiothorac Surg
. 2023
;18
(1
):124
. 23.
Antignani
P-L
, Lazarashvili
Z
, Monedero
JL
, Ezpeleta
SZ
, Whiteley
MS
, Khilnani
NM
, et al. Diagnosis and treatment of pelvic congestion syndrome: UIP consensus document
. Int Angiol
. 2019
;38
(4
):265
–83
. 24.
Nicholson
T
, Basile
A
. Pelvic congestion syndrome, who should we treat and how? Techniques in
. Tech Vasc Interv Radiol
. 2006
;9
(1
):19
–23
. 25.
Bałabuszek
K
, Toborek
M
, Pietura
R
. Comprehensive overview of the venous disorder known as pelvic congestion syndrome
. Ann Med
. 2022
;54
(1
):22
–36
. 26.
Rane
N
, Leyon
JJ
, Littlehales
T
, Ganeshan
A
, Crowe
P
, Uberoi
R
. Pelvic congestion syndrome
. Curr Probl Diagn Radiol
. 2013
;42
(4
):135
–40
. 27.
Bartl
T
, Wolf
F
, Dadak
C
. Pelvic congestion syndrome (PCS) as a pathology of postmenopausal women: a case report with literature review
. BMC Women’s Health
. 2021
;21
(1
):181
–5
. 28.
Wheelock
K
. Pelvic congestion syndrome and its relationship to varices of the lower extremities: a literature review
. J Diagn Med Sonography
. 2009
;25
(5
):250
–4
. 29.
Dos Santos
SJ
, Whiteley
MS
. Pelvic congestion syndrome masquerading as osteoarthritis of the hip
. SAGE Open Med Case Rep
. 2016
;4
:2050313X16683630
. 30.
Koo
S
, Fan
C-M
. Pelvic congestion syndrome and pelvic varicosities
. Tech Vasc Interv Radiol
. 2014
;17
(2
):90
–5
. 31.
Phillips
D
, Deipolyi
AR
, Hesketh
RL
, Midia
M
, Oklu
R
. Pelvic congestion syndrome: etiology of pain, diagnosis, and clinical management
. J Vasc Interv Radiol
. 2014
;25
(5
):725
–33
. 32.
Diwakar
P
. Pelvic congestion syndrome: a review of the treatment of symptomatic venous insufficiency in the ovarian and internal iliac veins by catheter-directed embolization
. Indian J Vasc Endovasc Surg
. 2018
;5
(4
):244
–52
. 33.
Kashef
E
, Evans
E
, Patel
N
, Agrawal
D
, Hemingway
AP
. Pelvic venous congestion syndrome: female venous congestive syndromes and endovascular treatment options
. CVIR Endovasc
. 2023
;6
(1
):25
–14
. 34.
Valero
I
, Garcia-Jimenez
R
, Valdevieso
P
, Garcia-Mejido
JA
, Gonzalez-Herráez
JV
, Pelayo-Delgado
I
, et al. Identification of pelvic congestion syndrome using transvaginal ultrasonography. A useful tool
. Tomography
. 2022
;8
(1
):89
–99
. 35.
Stones
RW
. Pelvic vascular congestion—half a century later
. Clin Obstet Gynecol
. 2003
;46
(4
):831
–6
. 36.
Ganeshan
A
, Upponi
S
, Hon
LQ
, Uthappa
MC
, Warakaulle
DR
, Uberoi
R
. Chronic pelvic pain due to pelvic congestion syndrome: the role of diagnostic and interventional radiology
. Cardiovasc Intervent Radiol
. 2007
;30
(6
):1105
–11
. 37.
Alonso
V
, Sánchez-Abuín
A
, Velasco
JJ
, Marugán de Miguelsanz
JM
. Pelvic congestion syndrome secondary to a circumaortic left renal vein
. J Pediatr
. 2020
;220
:261
–2
. 38.
Steenbeek
MP
, van der Vleuten
CJM
, Schultze Kool
LJ
, Nieboer
TE
. Noninvasive diagnostic tools for pelvic congestion syndrome: a systematic review
. Acta Obstet Gynecol Scand
. 2018
;97
(7
):776
–86
. 39.
Gullo
G
, Etrusco
A
, Cucinella
G
, Perino
A
, Chiantera
V
, Laganà
AS
, et al. Fertility-sparing approach in women affected by stage I and low-grade endometrial carcinoma: an updated overview
. Int J Mol Sci
. 2021
;22
(21
):11825
. 40.
Rezaei-Kalantari
K
, Fahrni
G
, Rotzinger
DC
, Qanadli
SD
. Insights into pelvic venous disorders
. Front Cardiovasc Med
. 2023
;10
:1102063
. 41.
Abi Antoun
M
, Etrusco
A
, Chiantera
V
, Laganà
AS
, Feghali
E
, Khazzaka
A
, et al. Outcomes of conventional and advanced energy devices in laparoscopic surgery: a systematic review
. Minim Invasive Ther Allied Technol
. 2024
;33
(1
):1
–12
. 42.
Jurga-Karwacka
A
, Karwacki
GM
, Schoetzau
A
, Zech
CJ
, Heinzelmann-Schwarz
V
, Schwab
FD
. A forgotten disease: pelvic congestion syndrome as a cause of chronic lower abdominal pain
. PLoS One
. 2019
;14
(4
):e0213834
. 43.
Park
J
. A case of pelvic congestion syndrome with chronic lower abdominal pain and vaginal spotting in a woman of childbearing age
. 2013
.© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
